With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.90319-52-1,(R)-4-Phenyloxazolidin-2-one,as a common compound, the synthetic route is as follows.
Step A: Preparation of (R,E)-3-(3-(3,5-difluorophenyl)acryloyl)-4- phenyloxazolidin-2-one: To a solution of (E)-3-(3,5-difluorophenyl)acrylic acid (10.0 g, 54.3 mmol) in Et20 (150 mL) at 0 ¡ãC was added DIEA (9.48 mL, 54.3 mmol) followed by pivaloyl chloride (6.69 mL, 54.3 mmol). The mixture was stirred at 0 ¡ãC for 1 hour and cooled to – 78 ¡ãC. Meanwhile (R)-4-phenyloxazolidin-2-one (8.86 g, 54.3 mmol) in THF (200 mL) was cooled to -78 ¡ãC and butyllithium (21.7 mE, 2.5 M, 54.3 mmol) was added slowly. The mixture was stirred for 20 minutes at -78 ¡ãC and transferred by cannula to the solution of mixed anhydride. The combined mixture was stirred at -78 ¡ãC for 15 mm, allowed to warm to 0 ¡ãC and stirred for an additional 30 minutes. The reaction mixture was quenched with saturated NH4CI (25 mL), diluted with EtOAc (600 mL), washed with water, NaHCO3, and brine, dried over MgSO4, and concentrated in vacuo. The crude material was purified by silica column chromatography, eluting with 10-20percent Ethyl acetate/Hexanes to afford the product (11.0 g, 61.5percent yield)., 90319-52-1
The synthetic route of 90319-52-1 has been constantly updated, and we look forward to future research findings.
Reference£º
Patent; ARRAY BIOPHARMA INC.; ALLEN, Shelley; BRANDHUBER, Barbara, J.; KERCHER, Timothy; KOLAKOWSKI, Gabrielle, R.; WINSKI, Sharon, L.; WO2014/78323; (2014); A1;,
Oxazolidine – Wikipedia
Oxazolidine | C3H7NO – PubChem